Dyne Therapeutics, Inc. DYN Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Research And Development Expense by Product | ||||||
| DYNE-101DM1 | $14.78M-67.5% | $27.11M+28.9% | $37.85M+22.4% | $34.68M+153% | $45.43M+440% | |
| DYNE-251DM1 | $37.75M+79.0% | $25.65M-7.7% | $22.67M-21.9% | $29.53M+36.2% | $21.09M+76.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Dyne Therapeutics, Inc. break its business down?
- Dyne Therapeutics, Inc. (DYN) reports research and development expense by product across 2 parts — DYNE-101DM1 and DYNE-251DM1. Each is extracted from the segment footnotes and tracked over time.
- Where does Dyne Therapeutics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Dyne Therapeutics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.